NARI News and Press, Inari Medical Inc. From 04/09/24

2024-04-09 16:49:42 ET Summary AngioDynamics has sold low-growth businesses, shifted to an outsourced manufacturing model, and refocused on cardiovascular and oncological care for potential growth. The recent approval of the AlphaVac F18 mechanical thrombectomy system for pulmonar...

Hagens Berman, National Trial Attorneys, Encourages NARI Investors with Substantial Losses Encouraged to Contact Firm SAN FRANCISCO, CA / ACCESSWIRE / April 3, 2024 / Hagens Berman urges Inari Medical, Inc. (NASDAQ:NARI) investors who suffered substantial losses to submit your losses now ...

2024-04-03 11:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the appointment of Tim Benner as Senior Vice President of U.S. Sales and Dr. Andrew Niekamp as Vice President of Medical Affairs. Mr. Benner will be responsible for devel...

SAN FRANCISCO, March 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/nari Contact An Attorney Now: NARI@hbsslaw.com 8...

2024-03-27 16:05:32 ET Summary Inari Medical, Inc.'s share price has dropped due to an investigation on doctor payment practices, creating a buying opportunity for risk-willing investors. Inari creates mechanical thrombectomy products for VTE and PE, with high potential operating ...

2024-03-26 10:39:43 ET More on AppFolio AppFolio: GAAP Profitable And Growing At High 20s% CAGR AppFolio Q4 2023 Earnings Call Transcript AppFolio's Financial Resilience: Robust Free Cash Flows And Debt-Free Status AppFolio Non-GAAP EPS of $0.88 beats by $0.2...

AppFolio Set to Join S&P MidCap 400; Inari Medical to Join S&P SmallCap 600 AppFolio Set to Join S&P MidCap 400; Inari Medical to Join S&P SmallCap 600 PR Newswire NEW YORK , March 25, 2024 /PRNewswire/ -- AppFolio Inc. (NASD:APPF) will r...

2024-03-24 10:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-22 12:15:02 ET Truist Financial analyst issues BUY recommendation for NARI on March 22, 2024 10:01AM ET. The previous analyst recommendation was Buy. NARI was trading at $44.225 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curr...